Q3-osavuosiraportti
Äänite tulossa
1 päivä sitten
Tarjoustasot
First North Sweden
Määrä
Osto
35
Myynti
Määrä
7 304
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 35 | - | - | ||
| 500 | - | - | ||
| 400 | - | - | ||
| 100 | - | - | ||
| 27 | - | - |
Ylin
19,95VWAP
Alin
17,2VaihtoMäärä
1,9 105 150
VWAP
Ylin
19,95Alin
17,2VaihtoMäärä
1,9 105 150
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4-osavuosiraportti | 17.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3-osavuosiraportti | 18.11. | |
| 2025 Q2-osavuosiraportti | 26.8. | |
| 2024 Yhtiökokous | 15.5. | |
| 2025 Q1-osavuosiraportti | 8.5. | |
| 2024 Q4-osavuosiraportti | 17.2. |
Datan lähde: Millistream, Quartr
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·8.10.I have owned Coreline for a long time. You don't see much information about Renaparin® in the news feed. Shouldn't it be time to raise money now to invest/develop that product? Anyone familiar with this?
·2.9.Since there is not much written. Copy: Credits the user "Proximo" on Discord for the following The variables that can be adjusted are few. The selling price of a Globe catheter can be estimated at $7000, which with an exchange rate of 9.5 gives 66500 SEK. Corline's revenue consists of a coating fee. This is in turn divided into a larger part that is invoiced directly and a smaller part in the form of a royalty that is received when the catheter is used (sold?) by Kardium. A general average for coating fees in the industry is 3%. There is no public figure for what Corline's fee to Kardium is, but the CEO said in an interview in 2022 that it is in the upper single digits. It is not inconceivable that one of the best surfaces in the world has a slightly higher fee than average. However, "upper single digits" may have changed since then and to calculate correctly or at best low, 3% is used. Boston Scientific sold approximately 200,000 of its PFA catheters between Q1 2024 and Q1 2025 and is estimated to have 60% of the market. The total market is therefore estimated to be approximately 330,000 catheters in 2025-2026. This gives (all figures are estimates): Sales price Globe catheter: 66500 SEK Coating fee: 3% Corline's revenue per Globe catheter: 66500 * 3% = 2000 SEK Estimated net margin (EBIT) for Corline (according to CEO Henrik Nittmar): 60% Corline's profit per Globe catheter: 1200 SEK Total market: 330,000 catheters in 2026 (growing strongly annually and estimated to be 550,000 in 2027) What remains to be seen: How many catheters does Kardium coata need annually? At 11,000 catheters: 1200*11000 = profit 13.2 MSEK At 22,000 catheters: profit 26.4 MSEK At 33,000 catheters or 10% of the market: profit 39.6 MSEK. At 10% of the market in 2027, 55,000 catheters or profit 66 MSEK. Corline's burn rate is about 21 MSEK / year. Thus, about 18,000 catheters annually should be the limit for break-even with a coating fee of 3%. CEO Henrik Nittmar announced in August 2025 that the company does not need investments to match Kardium's current production capacity. The CEO has said on several occasions that license revenues could amount to 50 MSEK within a few years. Given that Kardium is doing the job, the net will be at least 90%. With a modest pe=20, the stock price should be 800, i.e. 2-3 times higher than today.·3.9.Yes. You're right. x2 in bid should be reasonable and as more months go by it will probably be x3
·3.7.Kardium doesn't seem to be listed? Is this one of the few opportunities to invest in that project?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Q3-osavuosiraportti
Äänite tulossa
1 päivä sitten
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·8.10.I have owned Coreline for a long time. You don't see much information about Renaparin® in the news feed. Shouldn't it be time to raise money now to invest/develop that product? Anyone familiar with this?
- ·2.9.Since there is not much written. Copy: Credits the user "Proximo" on Discord for the following The variables that can be adjusted are few. The selling price of a Globe catheter can be estimated at $7000, which with an exchange rate of 9.5 gives 66500 SEK. Corline's revenue consists of a coating fee. This is in turn divided into a larger part that is invoiced directly and a smaller part in the form of a royalty that is received when the catheter is used (sold?) by Kardium. A general average for coating fees in the industry is 3%. There is no public figure for what Corline's fee to Kardium is, but the CEO said in an interview in 2022 that it is in the upper single digits. It is not inconceivable that one of the best surfaces in the world has a slightly higher fee than average. However, "upper single digits" may have changed since then and to calculate correctly or at best low, 3% is used. Boston Scientific sold approximately 200,000 of its PFA catheters between Q1 2024 and Q1 2025 and is estimated to have 60% of the market. The total market is therefore estimated to be approximately 330,000 catheters in 2025-2026. This gives (all figures are estimates): Sales price Globe catheter: 66500 SEK Coating fee: 3% Corline's revenue per Globe catheter: 66500 * 3% = 2000 SEK Estimated net margin (EBIT) for Corline (according to CEO Henrik Nittmar): 60% Corline's profit per Globe catheter: 1200 SEK Total market: 330,000 catheters in 2026 (growing strongly annually and estimated to be 550,000 in 2027) What remains to be seen: How many catheters does Kardium coata need annually? At 11,000 catheters: 1200*11000 = profit 13.2 MSEK At 22,000 catheters: profit 26.4 MSEK At 33,000 catheters or 10% of the market: profit 39.6 MSEK. At 10% of the market in 2027, 55,000 catheters or profit 66 MSEK. Corline's burn rate is about 21 MSEK / year. Thus, about 18,000 catheters annually should be the limit for break-even with a coating fee of 3%. CEO Henrik Nittmar announced in August 2025 that the company does not need investments to match Kardium's current production capacity. The CEO has said on several occasions that license revenues could amount to 50 MSEK within a few years. Given that Kardium is doing the job, the net will be at least 90%. With a modest pe=20, the stock price should be 800, i.e. 2-3 times higher than today.·3.9.Yes. You're right. x2 in bid should be reasonable and as more months go by it will probably be x3
- ·3.7.Kardium doesn't seem to be listed? Is this one of the few opportunities to invest in that project?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
35
Myynti
Määrä
7 304
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 35 | - | - | ||
| 500 | - | - | ||
| 400 | - | - | ||
| 100 | - | - | ||
| 27 | - | - |
Ylin
19,95VWAP
Alin
17,2VaihtoMäärä
1,9 105 150
VWAP
Ylin
19,95Alin
17,2VaihtoMäärä
1,9 105 150
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4-osavuosiraportti | 17.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3-osavuosiraportti | 18.11. | |
| 2025 Q2-osavuosiraportti | 26.8. | |
| 2024 Yhtiökokous | 15.5. | |
| 2025 Q1-osavuosiraportti | 8.5. | |
| 2024 Q4-osavuosiraportti | 17.2. |
Datan lähde: Millistream, Quartr
Q3-osavuosiraportti
Äänite tulossa
1 päivä sitten
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4-osavuosiraportti | 17.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3-osavuosiraportti | 18.11. | |
| 2025 Q2-osavuosiraportti | 26.8. | |
| 2024 Yhtiökokous | 15.5. | |
| 2025 Q1-osavuosiraportti | 8.5. | |
| 2024 Q4-osavuosiraportti | 17.2. |
Datan lähde: Millistream, Quartr
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·8.10.I have owned Coreline for a long time. You don't see much information about Renaparin® in the news feed. Shouldn't it be time to raise money now to invest/develop that product? Anyone familiar with this?
- ·2.9.Since there is not much written. Copy: Credits the user "Proximo" on Discord for the following The variables that can be adjusted are few. The selling price of a Globe catheter can be estimated at $7000, which with an exchange rate of 9.5 gives 66500 SEK. Corline's revenue consists of a coating fee. This is in turn divided into a larger part that is invoiced directly and a smaller part in the form of a royalty that is received when the catheter is used (sold?) by Kardium. A general average for coating fees in the industry is 3%. There is no public figure for what Corline's fee to Kardium is, but the CEO said in an interview in 2022 that it is in the upper single digits. It is not inconceivable that one of the best surfaces in the world has a slightly higher fee than average. However, "upper single digits" may have changed since then and to calculate correctly or at best low, 3% is used. Boston Scientific sold approximately 200,000 of its PFA catheters between Q1 2024 and Q1 2025 and is estimated to have 60% of the market. The total market is therefore estimated to be approximately 330,000 catheters in 2025-2026. This gives (all figures are estimates): Sales price Globe catheter: 66500 SEK Coating fee: 3% Corline's revenue per Globe catheter: 66500 * 3% = 2000 SEK Estimated net margin (EBIT) for Corline (according to CEO Henrik Nittmar): 60% Corline's profit per Globe catheter: 1200 SEK Total market: 330,000 catheters in 2026 (growing strongly annually and estimated to be 550,000 in 2027) What remains to be seen: How many catheters does Kardium coata need annually? At 11,000 catheters: 1200*11000 = profit 13.2 MSEK At 22,000 catheters: profit 26.4 MSEK At 33,000 catheters or 10% of the market: profit 39.6 MSEK. At 10% of the market in 2027, 55,000 catheters or profit 66 MSEK. Corline's burn rate is about 21 MSEK / year. Thus, about 18,000 catheters annually should be the limit for break-even with a coating fee of 3%. CEO Henrik Nittmar announced in August 2025 that the company does not need investments to match Kardium's current production capacity. The CEO has said on several occasions that license revenues could amount to 50 MSEK within a few years. Given that Kardium is doing the job, the net will be at least 90%. With a modest pe=20, the stock price should be 800, i.e. 2-3 times higher than today.·3.9.Yes. You're right. x2 in bid should be reasonable and as more months go by it will probably be x3
- ·3.7.Kardium doesn't seem to be listed? Is this one of the few opportunities to invest in that project?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
35
Myynti
Määrä
7 304
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 35 | - | - | ||
| 500 | - | - | ||
| 400 | - | - | ||
| 100 | - | - | ||
| 27 | - | - |
Ylin
19,95VWAP
Alin
17,2VaihtoMäärä
1,9 105 150
VWAP
Ylin
19,95Alin
17,2VaihtoMäärä
1,9 105 150
Välittäjätilasto
Dataa ei löytynyt